Rex Bright
Executive Director
foamix pharmaceuticals
Smart AssaysÂ
Israel
Biography
Mr. Rex Bright is a specialty pharmaceuticals and biotech executive with extensive experience in dermatology. Mr. Bright has spent over 20 years as a startup and turnaround CEO, and most recently founded and served as President & CEO of SkinMedica until it was acquired by Allergan in 2012. Prior to SkinMedica, Mr. Bright was President of Allergan Skincare and spent 19 years at Johnson & Johnson leading their dermatology division, which included the launch of Retin-A. He served on the board of directors at RestorGenex, Inc. as Chair of the Audit Committee through the Company’s merger with Diffusion Pharmaceuticals in 2016. Mr. Bright is a member of the board of directors for Clarify Medical and MDRejuvenia. He completed executive programs at Harvard, Stanford and Northwestern University and holds a B.A. degree in Business Administration from Drury University in Springfield, Missouri.
Research Interest
Pharmaceutical science
